ETCTN Phase I Clinical Trial of CA-4948 (emavusertib) in Combination with FOLFOX Plus Bevacizumab as Frontline Treatment in Patients with Metastatic Colorectal Cancer Adult CIRB - Early Phase Emphasis Active Available to Open